Skip to content
Research To Practice | Oncology Videos cover art

All episodes

Research To Practice | Oncology Videos, 197 episodes. Page 1 of 2.

#
Title
1

Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

2

Ovarian Cancer — Microlearning Activity 1: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

3

Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies (Companion Faculty Lecture)

4

Prostate Cancer with PTEN Deficiency — An Interview with Dr Neeraj Agarwal (Companion Faculty Lecture)

5

Glucocorticoid Receptor Antagonists for Ovarian Cancer — An Interview with Professor Nicoletta Colombo (Companion Faculty Lecture)

6

HER2-Positive Gynecologic Cancers — Microlearning Activity 1: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

7

Antibody-Drug Conjugates for Multiple Myeloma — An Interview with Dr Douglas W Sborov (Companion Faculty Lecture)

8

Chronic Myeloid Leukemia — An Interview with Prof Andreas Hochhaus (Companion Faculty Lecture)

9

Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal (Companion Faculty Lecture)

10

Non-Hodgkin Lymphoma | Sonali M Smith, MD

11

Non-Hodgkin Lymphoma | Matthew Matasar, MD

12

Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer | Virginia Kaklamani, MD, DSc

13

Gastroesophageal Cancers | Kohei Shitara, MD

14

Gastroesophageal Cancers | David H Ilson, MD, PhD

15

Multiple Myeloma | Amrita Krishnan, MD

16

Multiple Myeloma | Robert Z Orlowski, MD, PhD

17

Therapeutic Targets Beyond EGFR for Non-Small Cell Lung Cancer | Maurice Pérol, MD

18

Therapeutic Targets Beyond EGFR for Non-Small Cell Lung Cancer | John V Heymach, MD, PhD

19

HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy (Companion Faculty Lecture)

20

Endometrial Cancer — Microlearning Activity 1: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

21

Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay (Companion Faculty Lecture)

22

First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck (Companion Faculty Lecture)

23

Small Cell Lung Cancer | Jacob Sands, MD

24

Small Cell Lung Cancer | Christine L Hann, MD, PhD

25

Oral SERDs for Breast Cancer | Erica Mayer, MD, MPH, FASCO

26

EGFR-Mutant Non-Small Cell Lung Cancer | Helena Yu, MD

27

Squamous Cell Carcinoma of the Anal Canal — An Interview with Dr Marwan Fakih (Companion Faculty Lecture)

28

Breast Cancer — Microlearning Activity 3 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

29

Acute Myeloid Leukemia — An Interview with Dr Ghayas Issa on the Role of Menin Inhibitors (Companion Faculty Lecture)

30

Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management (Companion Faculty Lecture)

31

Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

32

Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

33

Acute Myeloid Leukemia — An Interview with Dr Jorge Cortes on Optimal Management of FLT3 and IDH1/2 Mutations (Companion Faculty Lecture)

34

IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies (Companion Faculty Lecture)

35

Myelofibrosis | John Mascarenhas, MD

36

Non-Hodgkin Lymphoma | Stephen M Ansell, MD, PhD

37

Non-Hodgkin Lymphoma | Brian T Hill, MD, PhD

38

5-Minute Journal Club Issue 8 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

39

Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies

40

5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

41

Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy

42

Prostate Cancer | Emmanuel S Antonarakis, MD

43

Prostate Cancer | Professor Karim Fizazi, MD, PhD

44

Non-Hodgkin Lymphoma — An Interview with Dr John P Leonard on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting (Companion Faculty Lecture)

45

Breast Cancer | Nancy U Lin, MD

46

Breast Cancer | Rebecca A Dent, MD, MSc

47

Chronic Lymphocytic Leukemia | Jennifer R Brown, MD, PhD

48

Chronic Lymphocytic Leukemia | Paolo Ghia, MD, PhD

49

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy (Companion Faculty Lecture)

50

Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Bispecific Antibodies

51

Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting (Companion Faculty Lecture)

52

First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor (Companion Faculty Lecture)

53

Breast Cancer — An Interview with Dr Adrienne G Waks on Recent Trial Updates (Companion Faculty Lecture)

54

ER-Positive Metastatic Breast Cancer | 5-Minute Journal Club Issue 6 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

55

Colorectal Cancer | Scott Kopetz, MD, PhD

56

Colorectal Cancer | Jeffrey Meyerhardt, MD, MPH

57

5-Minute Journal Club Issue 5 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

58

Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy (Companion Faculty Lecture)

59

EGFR-Mutant Non-Small Cell Lung Cancer | Helena Yu, MD

60

5-Minute Journal Club Issue 4 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

61

EGFR-Mutant Non-Small Cell Lung Cancer | Enriqueta Felip, MD, PhD

62

Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani (Companion Faculty Lecture)

63

5-Minute Journal Club Issue 3 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

64

ER-Positive Metastatic Breast Cancer | 5-Minute Journal Club: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer — Issue 2

65

Paroxysmal Nocturnal Hemoglobinuria | Jamile M Shammo, MD

66

ER-Positive Metastatic Breast Cancer | 5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

67

Tenosynovial Giant Cell Tumor | Oncology Today with Dr Neil Love: Optimizing the Management of Tenosynovial Giant Cell Tumor (Companion Faculty Lecture)

68

Lymphoma | Gilles Salles, MD, PhD

69

HR-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer (Companion Faculty Lecture)

70

Chronic Myeloid Leukemia | Jorge Cortes, MD

71

Peripheral T-Cell Lymphoma | Oncology Today with Dr Neil Love: Peripheral T-Cell Lymphoma (Companion Faculty Lecture)

72

Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer (Companion Faculty Lecture)

73

Neuroendocrine Tumors | Pamela Kunz, MD

74

Neuroendocrine Tumors | Simron Singh, MD, MPH

75

Gastrointestinal Cancers | Tanios Bekaii-Saab, MD

76

HR-Positive and Triple-Negative Metastatic Breast Cancer | Sara M Tolaney, MD, MPH

77

Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Urothelial Bladder Cancer

78

Non-Small Cell Lung Cancer | Professor Solange Peters, MD, PhD

79

Non-Small Cell Lung Cancer | Professor Ben Solomon, MBBS, PhD

80

HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer

81

HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer (Companion Faculty Lecture)

82

Non-Small Cell Lung Cancer | Karen Reckamp, MD, MS

83

Acute Lymphoblastic Leukemia | Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Companion Faculty Lecture)

84

Acute Lymphoblastic Leukemia | Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

85

Multiple Myeloma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma (Companion Faculty Lecture)

86

Multiple Myeloma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma

87

Acute Myeloid Leukemia | Naval Daver, MD

88

Colorectal Cancer | Thierry André, MD

89

HER2-Positive and Triple-Negative Breast Cancer | Priyanka Sharma, MD

90

Gastroesophageal Cancers | Yelena Y Janjigian, MD

91

Gastroesophageal Cancers | Zev Wainberg, MD, MSc

92

Biliary Tract Cancer | Lipika Goyal, MD, MPhil

93

Non-Small Cell Lung Cancer | Aaron Lisberg, MD

94

Non-Small Cell Lung Cancer | Luis Paz-Ares, MD, PhD

95

Nonmelanoma Skin Cancer | Anna C Pavlick, DO, MBA

96

Lung Cancer | Jamie E Chaft, MD

97

Multiple Myeloma | What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma (Companion Faculty Lecture)

98

Colorectal Cancer | J Randolph Hecht, MD

99

Colorectal Cancer | Kristen K Ciombor, MD, MSCI

100

Blastic Plasmacytoid Dendritic Cell Neoplasm | Oncology Today with Dr Neil Love: Blastic Plasmacytoid Dendritic Cell Neoplasm